Search results
Sanofi enters partnership to enhance drug development using AI
Pharmaceutical Technology via Yahoo Finance· 3 days agoSanofi has collaborated with Formation Bio and OpenAI to harness AI to expedite drug development. To...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoSanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...
In the Wake of 'Amgen v. Sanofi,' the USPTO Clarifies the Patent Enablement Requirement | The Legal...
Law.com· 5 hours agoThe Supreme Court unanimously affirmed the determination that Amgen’s claims covering a genus of...
Sanofi Drug Shows Promise in Asthma After Blood Disorder Success
Bloomberg· 2 days agoA Sanofi experimental drug showed promise in treating asthma, supporting the French drugmaker’s plan...
Chutes & Ladders—CRISPR Therapeutics finds new CMO in Sanofi leader
FierceBiotech· 8 hours agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Idorsia’s Jean-Paul Clozel retires as CEO, plots next steps; CRISPR Therapeutics nabs CMO from ...
Endpoints News· 9 hours ago→ Jean-Paul Clozel is ready to pass the torch at his Actelion follow-up Idorsia, but he doesn’t want to walk away from the company altogether. Jörn Aldag, Felix Ehrat and Peter Kellogg are stepping ...
Q3 2024 EPS Estimates for Sanofi (NASDAQ:SNY) Increased by Analyst
ETF DAILY NEWS· 3 days agoSanofi (NASDAQ:SNY – Free Report) – Research analysts at Zacks Research raised their Q3 2024 EPS estimates for Sanofi in a report released on Thursday, ...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks via Yahoo Finance· 3 days agoSanofi SNY announced that it has entered into a first-in-class artificial intelligence (AI)...
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To...
Benzinga via AOL· 2 days agoA judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA...
Drugmaker Sanofi partners OpenAI, Formation Bio on AI-powered drug development
Investing.com· 4 days agoDrugmaker Sanofi partners OpenAI, Formation Bio on AI-powered drug development